ReviewFrontiers in immunology2021

Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.

Marianna Nachef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.